학술논문
5.16 Pulse-Dosed Lenalidomide in Relapsed/Refractory Chronic Lymphocytic Leukemia: Immune Activation Correlates with Favorable Responses
Document Type
Abstract
Author
Source
In Clinical Lymphoma Myeloma and Leukemia October 2011 11 Supplement 2:S252-S253
Subject
Language
ISSN
2152-2650